Nikolin S

University of New South Wales, Australia.

4 papers · ORCID

ArticleKetamine

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

Glozier N, Morris R, Stratton E +21

Europe PMC2026
ArticleKetamine

Time matters for metas: a systematic review and meta-analysis of ect vs ketamine for depression incorporating time.

Nikolin S, Massaneda-Tuneu C, Brettell L +1

Europe PMC2026
ArticleKetamine

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Loo C, Glozier N, Barton D +35

Europe PMC2023
ArticleKetamine

Ketamine for the treatment of major depression: a systematic review and meta-analysis.

Nikolin S, Rodgers A, Schwaab A +4

Europe PMC2023